Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHargreave Regulatory News (HHV)

Share Price Information for Hargreave (HHV)

Share Price is delayed by 15 minutes
Get Live Data
31.30    0.00 (0.00%)
Bid:
30.60
Ask:
32.00
Spread: 1.40 (4.575%)
Market Cap: £117.36m
HHV Live PriceLast checked at - London Stock Exchange

Intraday Hargreave Share Chart

Offer Update

15 Apr 2021 07:00

Offer Update

15 April 2021

HARGREAVE HALE AIM VCT PLC (the “Company”)

Close of Offer to Further Applications

On 2 September 2020, the Company launched an offer for subscription (the “Offer”) of Ordinary Shares of 1p each in the capital of the Company to raise up to £20 million, together with an Over-allotment facility of up to a further £10 million. Full details of the Offer are contained in a prospectus which was published by the Company on 2 September 2020 and a supplementary prospectus published on 8 January 2021.

On 7 January 2021, the Company announced that it had received valid applications in excess of £19 million and therefore intended to utilise the £10 million Over-allotment Facility. On 15 February 2021, the Company confirmed it had received valid applications in respect of the full £10 million Over-allotment facility.

The Directors of the Company today announce that the Offer is now fully subscribed and closed for further applications.

Terms defined in the Prospectus have the same meaning where used in this announcement.

END

For further information, please contact:

JTC (UK) LimitedSusan.FadilRuth WrightHHV.CoSec@jtcgroup.com +44 20 3893 1005 +44 203 893 1011

LEI: 213800LRYA19A69SIT31

Date   Source Headline
30th Jan 20254:43 pmGNWTransaction in Own Shares
28th Jan 20253:49 pmGNWNet Asset Value(s)
23rd Jan 20254:53 pmGNWTransaction in Own Shares
21st Jan 20254:33 pmGNWNet Asset Value(s)
16th Jan 20259:40 amGNWIssue of Equity
15th Jan 20254:35 pmGNWTransaction in Own Shares
14th Jan 20254:10 pmGNWNet Asset Value(s)
9th Jan 202512:37 pmGNWNet Asset Value(s)
31st Dec 202410:57 amGNWNet Asset Value(s)
31st Dec 202410:14 amGNWTotal voting rights
23rd Dec 20243:56 pmGNWNet Asset Value(s)
20th Dec 202412:00 pmGNWPublication of a supplementary prospectus
18th Dec 20244:18 pmGNWTransaction in Own Shares
18th Dec 20247:04 amGNWNet Asset Value(s)
18th Dec 20247:02 amGNWRecord Date for Special and Final Dividends
18th Dec 20247:00 amGNWFull year Results and Notice of AGM
13th Dec 20244:23 pmGNWDirectorate change
12th Dec 20243:57 pmGNWIssue of Equity
11th Dec 20245:03 pmGNWCorrection: Transaction in Own Shares
11th Dec 20243:41 pmGNWIssue of Equity
10th Dec 20244:34 pmGNWNet Asset Value(s)
9th Dec 20249:47 amGNWOffer Update – Extension of Early Bird Discount Period
4th Dec 20244:48 pmGNWTransaction in Own Shares
3rd Dec 20244:25 pmGNWNet Asset Value(s)
29th Nov 20244:28 pmGNWTotal voting rights
27th Nov 20245:02 pmGNWTransaction in Own Shares
26th Nov 20244:18 pmGNWNet Asset Value(s)
25th Nov 20247:00 amGNWInterim Management Statement Q4 2024
20th Nov 20245:01 pmGNWTransaction in Own Shares
19th Nov 20244:14 pmGNWNet Asset Value(s)
15th Nov 20247:00 amGNWClosed Period Notification
13th Nov 20244:13 pmGNWIssue of Equity
12th Nov 20244:39 pmGNWTransaction in Own Shares
12th Nov 20243:04 pmGNWResult of General Meeting
12th Nov 20249:49 amGNWNet Asset Value(s)
5th Nov 20243:57 pmGNWNet Asset Value(s)
31st Oct 20241:05 pmGNWTotal voting rights
30th Oct 20244:18 pmGNWTransaction in Own Shares
29th Oct 20241:33 pmGNWNet Asset Value(s)
23rd Oct 20244:38 pmGNWTransaction in Own Shares
22nd Oct 20245:06 pmGNWNet Asset Value(s)
16th Oct 20245:00 pmGNWTransaction in Own Shares
15th Oct 20245:01 pmGNWNet Asset Value(s)
10th Oct 20244:46 pmGNWPublication of a Circular - Notice of General Meeting
10th Oct 20249:51 amGNWNet Asset Value(s)
9th Oct 20244:36 pmGNWPublication of a Prospectus and Relevant Related Party Transaction
2nd Oct 20244:54 pmGNWTransaction in Own Shares
1st Oct 20241:21 pmGNWNet Asset Value(s)
30th Sep 20243:42 pmGNWTotal voting rights
25th Sep 20244:57 pmGNWTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.